Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarisse Scherer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|June 26, 2009
[Multiple sclerosis]Clarisse Scherer, Frédéric Dubas
Neuroepidemiology|January 10, 2026
Epidemiology of Amyotrophic Lateral Sclerosis in the Pays de la Loire, France: A 20-Year Study from a Centralized Diagnostic CenterMarie-Lou Chevet, Maelle Garnier, Marc Fadel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 25, 2023
"Ten euros now" temporal discounting in Huntington diseaseMohamad El Haj, Marie Caillaud, Ahmed Moustafa, et al.
Clinical Neurology and Neurosurgery|June 12, 2013
Adult-onset cerebral X-linked adrenoleukodystrophy with major contrast-enhancement mimicking acquired diseaseClarisse Carra-Dalliere, Clarisse Scherer, Xavier Ayrignac, et al.
Acta Neuropathologica Communications|February 10, 2026
Exploratory assessment of phosphorylated TDP-43 immunoreactivity in minor salivary glands of patients with ALSMaelle Garnier, Julien Gouju, Audrey Rousseau, et al.
Epilepsia|May 28, 2008
Analysis of clinical patterns and underlying epileptogenic zones of hypermotor seizuresSylvain Rheims, Philippe Ryvlin, Clarisse Scherer, et al.
Neuropsychologia|July 18, 2017
Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's diseaseNajia Adjeroud, Jeremy Besnard, Christophe Verny, et al.
Social Cognitive and Affective Neuroscience|July 27, 2015
Theory of mind and empathy in preclinical and clinical Huntington's diseaseNajia Adjeroud, Jérémy Besnard, Nicole El Massioui, et al.
Fundamental & Clinical Pharmacology|April 8, 2014
The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trialsLinda Salem, Nadine Saleh, Katia Youssov, et al.
Neurocase|November 28, 2019
Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case reportMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|June 26, 2009
[Multiple sclerosis]Clarisse Scherer, Frédéric Dubas
Neuroepidemiology|January 10, 2026
Epidemiology of Amyotrophic Lateral Sclerosis in the Pays de la Loire, France: A 20-Year Study from a Centralized Diagnostic CenterMarie-Lou Chevet, Maelle Garnier, Marc Fadel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 25, 2023
"Ten euros now" temporal discounting in Huntington diseaseMohamad El Haj, Marie Caillaud, Ahmed Moustafa, et al.
Clinical Neurology and Neurosurgery|June 12, 2013
Adult-onset cerebral X-linked adrenoleukodystrophy with major contrast-enhancement mimicking acquired diseaseClarisse Carra-Dalliere, Clarisse Scherer, Xavier Ayrignac, et al.
Acta Neuropathologica Communications|February 10, 2026
Exploratory assessment of phosphorylated TDP-43 immunoreactivity in minor salivary glands of patients with ALSMaelle Garnier, Julien Gouju, Audrey Rousseau, et al.
Epilepsia|May 28, 2008
Analysis of clinical patterns and underlying epileptogenic zones of hypermotor seizuresSylvain Rheims, Philippe Ryvlin, Clarisse Scherer, et al.
Neuropsychologia|July 18, 2017
Dissociation between decision-making under risk and decision-making under ambiguity in premanifest and manifest Huntington's diseaseNajia Adjeroud, Jeremy Besnard, Christophe Verny, et al.
Social Cognitive and Affective Neuroscience|July 27, 2015
Theory of mind and empathy in preclinical and clinical Huntington's diseaseNajia Adjeroud, Jérémy Besnard, Nicole El Massioui, et al.
Fundamental & Clinical Pharmacology|April 8, 2014
The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trialsLinda Salem, Nadine Saleh, Katia Youssov, et al.
Neurocase|November 28, 2019
Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case reportMarie Caillaud, Mickael Laisney, Alexandre Bejanin, et al.
Pageof 3